News for Healthier Living

Johns Hopkins Investigators Identify a Metabolic Weak Point in Exhausted Immune Cells in Head and Neck Cancer

Immune cells can reach head and neck tumors, but once there, many stop functioning. This helps explain why immunotherapy with immune checkpoint inhibitors -- which have transformed treatment for some cancers -- benefit only 17%-23% of patients with head and neck squamous cell carcinoma. These are cancers that arise from cells lining the mouth, throat and voicebox.

September 30, 2026


October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026

September 25 2026

September 24 2026

September 23 2026

September 22 2026

September 21 2026

September 18 2026

September 17 2026